Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956. 

Biotechnology

Life Sciences

Pharmaceutical

Regis Technologies

Richard Myer

Burr Martin

Melissa Wilcox

Alan Henderson

Alyson Battis

James Letzkus

Judy Koppe

Katie Kretschmer

Samantha Wijeweera

Sophia Imeroni

Charvi Payghode

James Colegrove

Julius Jackson

Steven Leyvi

Lakulish Patel

Burrous Martin

Adam Fox

Simeon Pickett

Chemistry and Research Team

Operations

Quality Assurance and Control Team

Business Development and Operations

Leadership Team

Teams at Regis Technologies

Chemistry and Research Team

Operations

Quality Assurance and Control Team

Business Development and Operations

Leadership Team